Subjective Outcome
7 compoundsin Regimen’s catalog are configured to track joint pain via Rate Today. Each one shows the dose range, listed benefits, and every outcome it’s set up to monitor. Tap through to plan a dose with the free reconstitution calculator.
The peptides most associated with joint and tendon recovery — BPC-157, TB-500 (thymosin beta-4), and GHK-Cu — have a body of preclinical evidence but limited human RCT data. BPC-157 in particular has extensive rodent literature on tendon healing, gut repair, and angiogenesis, but the human trial dataset is sparse and the FDA has not approved it for any indication.
For users who report symptomatic relief, the typical protocol pairs systemic BPC-157 with localized injection at or near the site of injury, often alongside TB-500. The mechanism cited is upregulation of growth factors (VEGF, FGF) and tissue repair pathways. Whether the effect outperforms placebo in a controlled trial remains an open question.
GH secretagogues (CJC-1295, ipamorelin) are sometimes used adjunctively for connective-tissue repair via the IGF-1 axis. The evidence for tendon-specific healing is stronger here than for BPC-157 in humans, but still mostly indirect.
Anchor citation: Sikiric P et al.. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Current Neuropharmacology, 2016.
7 compounds
Body Protective Compound
A synthetic peptide with potent tissue-healing, gut-protective, and anti-inflammatory properties. Widely used for injury recovery and gut health.
Tracks
Thymosin Beta-4 fragment
Synthetic 17–amino-acid fragment of the naturally occurring Thymosin Beta-4 protein. Drives actin polymerization, accelerates wound and soft-tissue repair, and modulates inflammation through actin sequestration in injured tissue.
Tracks
Tracks
GHK-Cu / BPC-157 / TB-500
A regenerative peptide blend targeting skin quality, tissue repair, and systemic recovery.
Tracks
Zinc-bound Thymic Immunomodulator
A nonapeptide secreted by thymic epithelial cells that requires zinc for biological activity. Studied for T-cell maturation, NF-κB suppression, and dampening of pro-inflammatory cytokines, primarily in animal models.
Tracks
α-MSH C-terminal Anti-Inflammatory Tripeptide
A tripeptide corresponding to the C-terminal fragment of α-melanocyte-stimulating hormone (Lys-Pro-Val). Anti-inflammatory in vitro and in vivo via PepT1-mediated cellular uptake (not melanocortin receptor signaling), with nanomolar inhibition of NF-κB and MAP kinase pathways.
Tracks
KPV / GHK-Cu / BPC-157 / TB-500
A regenerative, anti-inflammatory peptide blend that adds KPV to the GLOW base (GHK-Cu, BPC-157, TB-500) for extra immune and gut-inflammation support alongside skin quality and tissue repair.
Tracks
Animal evidence is consistent and positive across many studies. Human evidence is anecdotal and from small case series. The strongest claim that can be made honestly is: the preclinical signal is strong enough to justify ongoing research, but the absence of FDA-controlled RCTs means it remains experimental. Anyone using BPC-157 should treat it as such.
Typical anecdotal protocols are 4–8 weeks at 250–500 mcg/day, often dosed twice daily. Localized injection at or near the injury site is reported to work faster than systemic-only dosing. There is no FDA-approved dosing schedule; these numbers come from compounding pharmacy practice and user reports, not regulatory guidance.
Yes. Regimen’s Rate Today scoring includes joint pain as a daily 1–5 dimension, and the sparkline displays next to the protocol’s dose log. Pair the rating with the Reactions Journal for any localized swelling, soreness, or injection-site response — the combined picture is the closest thing to a personal trial.
Related reading
Best peptide tracker app in 2026
An honest multi-protocol comparison of Regimen, PeptIQ, Shotsy, MeAgain, and the GLP-1 calculator apps.
Other outcomes